Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oscar Lilleby

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Urology Case Reports|August 28, 2019
Metastatic-directed therapy using PSMA-PET/CT at PSA relapseOscar Lilleby, Eivor Hernes, Wolfgang Lilleby
Scandinavian Journal of Urology|June 20, 2023
Current evidence for moderate and ultra-hypofractionated radiation therapy in prostate cancer: a summary of the results from phase 3 randomised trialsOscar Lilleby, Peter Meidahl Petersen, Gedske Daugaard, et al.
Cancers|December 5, 2020
Ablative Radiotherapy in Prostate Cancer: Stereotactic Body Radiotherapy and High Dose Rate BrachytherapyTing Martin Ma, Oscar Lilleby, Wolfgang A Lilleby, et al.
Journal of Personalized Medicine|April 30, 2021
The Quandary of DNA-Based Treatment Assessment in De Novo Metastatic Prostate Cancer in the Era of Precision OncologySigve Nakken, Wolfgang Lilleby, Marta D Switlyk, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Urology Case Reports|August 28, 2019
Metastatic-directed therapy using PSMA-PET/CT at PSA relapseOscar Lilleby, Eivor Hernes, Wolfgang Lilleby
Scandinavian Journal of Urology|June 20, 2023
Current evidence for moderate and ultra-hypofractionated radiation therapy in prostate cancer: a summary of the results from phase 3 randomised trialsOscar Lilleby, Peter Meidahl Petersen, Gedske Daugaard, et al.
Cancers|December 5, 2020
Ablative Radiotherapy in Prostate Cancer: Stereotactic Body Radiotherapy and High Dose Rate BrachytherapyTing Martin Ma, Oscar Lilleby, Wolfgang A Lilleby, et al.
Journal of Personalized Medicine|April 30, 2021
The Quandary of DNA-Based Treatment Assessment in De Novo Metastatic Prostate Cancer in the Era of Precision OncologySigve Nakken, Wolfgang Lilleby, Marta D Switlyk, et al.
Pageof 1